ArticleFrontiers in immunology2020

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies.

Agnieszka Tomaszewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.